Magenta Therapeutics, Inc.·4

Aug 1, 9:11 PM ET

Mahoney Stephen F. 4

4 · Magenta Therapeutics, Inc. · Filed Aug 1, 2022

Insider Transaction Report

Form 4
Period: 2022-08-01
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-08-01+130,000130,000 total
    Exercise: $1.57Exp: 2032-07-31Common Stock (130,000 underlying)
Footnotes (1)
  • [F1]This option shall vest and become exercisable in 16 equal quarterly installments beginning on the first quarter following the vesting commencement date. The vesting commencement date is August 1, 2022.

Documents

2 files